FIELD: medical science.
SUBSTANCE: invention refers to ophthalmology, namely to a hypoosmotic ophthalmic agent for ultraviolet cross-linking. Hypo-osmotic ophthalmic agent for ultraviolet cross-linking in keratectasias with a corneal thickness of 350-400 mcm, containing riboflavin mononucleotide, hydroxypropyl methyl cellulose as a base and purified distilled water 100 ml, wherein riboflavin mononucleotide in amount of 0.075 g and hydroxypropyl methyl cellulose in amount of 0.025 g.
EFFECT: use of said invention provides a stable artificial intraoperative stroma oedema and an increase in the corneal thickness to 400 mcm or more when performing standard UV cross-linking in patients with thin cornea 350-400 mcm, maintaining the required concentration of the active substance due to the optimum composition of the components.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYPOSMOTIC OPHTHALMIC MEANS FOR ULTRAVIOLET CROSSLINKING OF THIN CORNEAS | 2016 |
|
RU2631604C1 |
| OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
| OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
| METHOD OF TREATMENT OF KERATECTASIA BY THE METHOD OF PULSE ACCELERATED ULTRAVIOLET CROSSLINKING OF CORNEA | 2017 |
|
RU2682494C1 |
| METHOD OF TREATING KERATOCONUS STAGE I-II | 2022 |
|
RU2819801C2 |
| OPHTHALMIC CROSS-LINKING AGENT-2 | 2012 |
|
RU2475248C1 |
| CROSS-LINKING OPHTHALMIC AGENT | 2009 |
|
RU2412707C1 |
| OPHTHALMOLOGICAL MEANS FOR CORNEAL INJURIES AND DISEASES DIAGNOSTICS | 2016 |
|
RU2633083C1 |
| METHOD OF TREATING EPITHELIAL-ENDOTHELIAL CORNEAL DYSTROPHY | 2019 |
|
RU2703361C1 |
| METHOD OF CORNEAL GRAFT PREPARATION FOR LAYER-BY-LAYER KERATOPLASTY | 2019 |
|
RU2723135C1 |
